Generated by AI
Vivani Medical Inc. is a clinical-stage biopharmaceutical company focused on developing miniature, ultra long-acting subdermal drug implants using its proprietary NanoPortal technology. The company’s current work centers on implant-based therapies designed to deliver medicines steadily over extended periods, with an emphasis on improving medication adherence and tolerability in chronic diseases. Its product pipeline includes GLP-1-based implants under development for obesity, chronic weight management, and type 2 diabetes, reflecting a focus on metabolic health applications. Vivani Medical also operates a neuromodulation segment, broadening its presence in advanced implantable medical technologies. Headquartered in Alameda, California, the company plays a specialized role in the drug-delivery market by addressing challenges associated with frequent oral or injectable dosing through long-duration implant solutions.
Website1350 South Loop Road
Alameda, CA, 94502
United States
The latest articles about VANI.
Summary of Nov 12's posts. Generated by AI.
Summary of Jul 7's posts. Generated by AI.
Summary of Aug 8's posts. Generated by AI.
No summary yet.
Summary of Jul 25's posts. Generated by AI.
Investors talking about VANI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.